PDL BioPharma Seeks Ularitide Partner That Grants Rights To A Late-Stage Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
A more complicated partnership involving two clinical programs is taking more time to complete than a “ularitide-only” deal, the biotech says.